Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Sun Pharma ANZ Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (452)
Cancellation by sponsor (155)
Prescription medicine registration (29)
Section 14, TGO91 consent (5)
Australian public assessment report (AusPar) (4)
Prescription medicine decision summary (1)

Date

2026 (15)
2025 (40)
2024 (47)
2023 (36)
2022 (54)
2021 (42)
2020 (25)
2019 (26)
2018 (50)
2017 (18)
2016 (35)
2015 (20)
2014 (10)
2013 (22)
2012 (62)
2011 (92)
2010 (14)
2009 (13)
2007 (12)
2006 (10)
2005 (3)

Search

Sponsor content

646 result(s) found, displaying 201 to 210

DASATINIB RBX, DASATINIB SUN, DASATINIB RAN (Sun Pharma ANZ Pty Ltd)

18 July 2022

Prescription medicine registration

Active ingredients: Dasatinib.
FINGOLIMOD SUN fingolimod (as hydrochloride) 500 microgram capsule blister pack (317244)

9 September 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for FINGOLIMOD SUN fingolimod (as hydrochloride) 500 microgram capsule blister pack.
FINGOLIMOD RBX fingolimod (as hydrochloride) 500 microgram capsule blister pack (317246)

9 September 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for FINGOLIMOD RBX fingolimod (as hydrochloride) 500 microgram capsule blister pack.
FINGOLIMOD RAN fingolimod (as hydrochloride) 500 microgram capsule blister pack (317247)

9 September 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for FINGOLIMOD RAN fingolimod (as hydrochloride) 500 microgram capsule blister pack.
LISINOPRIL RANBAXY lisinopril 20 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
LISINOPRIL RANBAXY lisinopril 10 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
LAMIV lamivudine 100 mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
LAMIV lamivudine 100 mg tablets bottle Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
ATENOLOL RBX Atenolol 50 mg film coated tablets bottle Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
ATENOLOL RBX Atenolol 100 mg film coated tablets bottle Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd

Pages

First page
Previous page
…
Page 17
Page 18
Page 19
Page 20
Current page 21
Page 22
Page 23
Page 24
Page 25
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.